α2-Macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein

Blood Cells, Molecules, and Diseases

Volumn 24, Issue 4, 1998, Pages 412-419

  Heeb, Mary J ^a   España, Francisco ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Benign prostatic hyperplasia; C1 inactivator; Human glandular kallikrein; Prostate cancer; Protein C inhibitor; 2 macroglobulin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 ANTIPLASMIN; ALPHA 2 MACROGLOBULIN; ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; DIVALENT CATION; HEPARIN; INTER ALPHA TRYPSIN INHIBITOR; ISOENZYME; PLASMINOGEN ACTIVATOR INHIBITOR 3; PROSTATE SPECIFIC ANTIGEN; PROTEINASE INHIBITOR; TISSUE KALLIKREIN; ENZYME INHIBITOR; KALLIKREIN; TUMOR MARKER;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; ENZYME INHIBITOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REACTION TIME; SEMEN ANALYSIS; SEQUENCE HOMOLOGY; BLOOD; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; MALE; METABOLISM; PROSTATE TUMOR;

ALPHA-MACROGLOBULINS; COMPLEMENT C1 INACTIVATOR PROTEINS; ENZYME INHIBITORS; FEMALE; HUMANS; KALLIKREINS; MALE; PROSTATIC NEOPLASMS; TISSUE KALLIKREINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032217097     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0209     Document Type: Article

References (18)

1. 1. Darson MF, Pacelli A, Roche P, et al. Human glandular kallikren 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel postate cancer marker. Urology 49:857-862, 1997.
2. 2. Finlay JA, Evans CL, Day JR, Payne JK, et al. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): Development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Urology 51: 804-809, 1998.
3. 3. Schedlich U, Bennetts B, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 6:429-437, 1987.
4. 4. Chapdelaine P, Paradis G, Tremblay RR, Dubé JY. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett 236:205-208, 1988.
5. 5. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 57:3111-3114, 1997.
6. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 51:222-226, 1991.
7. 1-antichymotrypsin. Clin Chem 37:1618-1625, 1991.
8. 8. España F, Royo M, Martínez M, et al. Free and complexed prostate-specific antigen in the differentiation between benign prostatic hyperplasia and prostate cancer. Studies in serum and plasma samples. J Urol (in press), 1998.
9. 2-macroglobulin complexes in prostate cancer patient sera. Biochem Mol Biol Int 37:917-923, 1995.
10. 10. Chen Z, Komatsu K, Prestigiacomo A, Stamey TA. Addition of purified prostate specific antigen to serum from female subjects: Studies on the relative inhibition by α2-macroglobulin and α1-antichymotrypsin. J Urol 156:1357-1363, 1996.
11. 11. Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human serum. Eur J Biochem 220:45-53, 1994.
12. 12. Wilson MJ. Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer. J Lab Clin Med 131:298-299, 1998.
13. 13. Mikolajczyk SD, Millar LS, Marker ,auKM, et al. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur J Biochem 246:440-446, 1997.
14. 14. Heeb MJ, España F, Geiger M, Collen D, Stump DC, Griffin JH. Immunological identity of heparin- dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 262: 15813-15816, 1987.
15. 15. Grauer LS, Finlay JA, Mikolajczyk SD, Pusateri KD, Wolfert RL. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum. J Androl 19:407-411, 1998.
16. 16. Frenette G, Deperthes D, Tremblay RR, Lazure C, Dubé JY. Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochim Biophys Acta 1334:109-115, 1997.
17. 17. Deperthes D, Chapdelaine P, Tremblay RR, et al. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta 1245:311-316, 1995.
18. 2-macroglobulin. Clin Chem 42:545-550, 1996.